The
New York Times covered the Hepatitis B vaccine
debate: "Hepatitis B is more common in other countries, especially in parts of Africa and Asia, in part because of low vaccination rates. The World Health Organization
estimates that there are around 1.2 million new infections of hepatitis B each year globally. In 2022, the organization noted,
over one million people died after contracting the virus, largely because of liver complications...But babies who are infected in the first year of life have about a 90 percent chance of developing a chronic infection. And about 30 percent of children infected between the ages of 1 and 5 develop chronic hepatitis B. Left untreated, chronic infections can lead to irreversible liver damage, scarring, failure and cancer over time. These complications can be deadly."